Académique Documents
Professionnel Documents
Culture Documents
90
Symbol PRGO PERRIGO CO H&C Composite Score
Description Perrigo Company is a global healthcare supplier that develops, manufactures and
Strong Buy
distributes OTC and generic prescription pharmaceuticals, infant formulas,
nutritional products, active pharmaceutical ingredients and pharmaceutical and
medical diagnostic products. The Company's primary markets and locations of
8.3
manufacturing and logistics operations are the US, UK, Mexico, and Australia.
PERRIGO CO $82
$81
$80
$79
$78
$77
$76
$75
$74
$73
$72
$71
$70
$69
$68
$67
$66
$65
$64
$63
$62
$61
$60
10.0
Bull Trend Bear Trend
0.0
-10.0
2.0
Up / Down Volume Ratio
1.5
1.0
0.5
0.0
40
20
0
7-Dec-10 21-Dec-10 5-Jan-11 20-Jan-11 3-Feb-11 17-Feb-11 4-Mar-11 18-Mar-11 1-Apr-11
Volume x100,000
Fundamentals
PERRIGO CO
1
Earnings Per Share 2 Reported Estimate Target Price 19 Reported Estimate
$1.20 $90
$80
$1.00
$70
$0.80 $60
$50
$0.60
$40
$0.40 $30
$20
$0.20
$10
$0.00 $0
Total Revenues 1
Reported Estimate
Ownership EPS & Revenue Growth
Investment Advisor 79.54% Quarter EPS Growth Rev. Growth
$900
Individual 10.24% FQ3 2009 6% 5%
$800 Hedge Fund Manager 4.73% FQ4 2009 2% 18%
Pension Fund (ERISA) 2.94% FQ1 2010 55% 16%
$700 Mutual Fund Manager 1.39% FQ2 2010 48% 8%
Insurance Company 0.88% FQ3 2010 52% 6%
$600
Bank 0.24% FQ4 2010 45% 22%
$500 Unclassified 0.05% FQ1 2011 22% 21%
FQ2 2011 43% 23%
$400
Top Holders and % Outstanding Forward Growth Estimates
$300 FIDELITY MANAGEMENT 8.17% Quarter EPS Growth Rev. Growth
$200 ARKIN MOSHE 6.44% FQ3 2011 27% 28%
DELAWARE MANAGEMENT 4.58% FQ4 2011 39% 13%
$100 VANGUARD GROUP INC 4.02% FQ1 2012 29% 12%
WELLINGTON MANAGEMEN 3.43% FQ2 2012 17% 8%
$0
BLACKROCK FUND ADVIS 2.52%
STATE STREET CORP 2.42%
BLACKROCK INSTITUTIO 2.15%
Disclosure: This material is provided for information only and is not intended as a recommendation or an offer or solicitation for the purchase or sale of any security or financial instrument. This material is not a complete analysis of all material facts respecting any issuer, industry
or security or of your investment objectives, parameters, needs or financial situation, and therefore is not a sufficient basis alone on which to base an investment decision. Horowitz & Company clients may hold positions (long or short) in investments discussed. Please click for
detailed disclosures and additional information about our stock ratings and scoring.
4/3/2011